Market Whales and Their Recent Bets on ABT Options
Portfolio Pulse from Benzinga Insights
Financial giants have made significant bullish moves on Abbott Laboratories (NYSE: ABT) options, with 50% of traders being bullish. The price target for ABT is between $100.0 and $115.0. The stock is currently priced at $104.26, down 0.59%. Analysts have set an average price target of $123.0, with recent downgrades from Goldman Sachs and RBC Capital.
June 27, 2024 | 7:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Financial giants have shown a bullish sentiment on Abbott Laboratories (NYSE: ABT) options, with a significant portion of trades being calls. The stock is currently priced at $104.26, with analysts setting an average price target of $123.0. Recent downgrades from Goldman Sachs and RBC Capital indicate cautious optimism.
The bullish sentiment from significant options trades suggests positive short-term movement for ABT. Despite recent downgrades, the average price target remains higher than the current price, indicating potential upside.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100